The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Hanover Media Strategy Limited .

Filed returns
185
match these filters
Matching filed returns per period 0 5 10 15 20 Jan–Apr 2017: 2 filed returns May–Aug 2017: 6 filed returns Sep–Dec 2017: 5 filed returns Jan–Apr 2018: 3 filed returns May–Aug 2018: 2 filed returns Sep–Dec 2018: 3 filed returns Jan–Apr 2019: 3 filed returns May–Aug 2019: 4 filed returns Sep–Dec 2019: 4 filed returns Jan–Apr 2020: 6 filed returns May–Aug 2020: 7 filed returns Sep–Dec 2020: 6 filed returns Jan–Apr 2021: 6 filed returns May–Aug 2021: 4 filed returns Sep–Dec 2021: 1 filed returns Jan–Apr 2022: 3 filed returns May–Aug 2022: 5 filed returns Sep–Dec 2022: 6 filed returns Jan–Apr 2023: 10 filed returns May–Aug 2023: 9 filed returns Sep–Dec 2023: 13 filed returns Jan–Apr 2024: 8 filed returns May–Aug 2024: 14 filed returns Sep–Dec 2024: 12 filed returns Jan–Apr 2025: 7 filed returns May–Aug 2025: 10 filed returns Sep–Dec 2025: 13 filed returns Jan–Apr 2026: 6 filed returns May–Aug 2026: 7 filed returns 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Jan–Apr 2020 Hanover Media Strategy Limited Transport The impact of COVID-19 on the tourism sector in Ireland, and the specific impact it is having the Irish car rental industry (Legislation) 20 On lobbying.ie
Jan–Apr 2020 Hanover Media Strategy Limited Health Optimisation of Rheumatoid Arthritis pathway of care (Matters involving public funds) 10 On lobbying.ie
Jan–Apr 2020 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines (Matters involving public funds) 8 On lobbying.ie
Sep–Dec 2019 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines (Matters involving public funds) 2 On lobbying.ie
Sep–Dec 2019 Hanover Media Strategy Limited Transport Cost of Motor Insurance Policies in Ireland and the role of sustainable mobility solutions in climate action solutions. (Legislation) 3 On lobbying.ie
Sep–Dec 2019 Hanover Media Strategy Limited Health Creation of national policy with regard to Orphan Medicinal Products (Legislation) 1 On lobbying.ie
Sep–Dec 2019 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines & engage government on healthcare innovation (Matters involving public funds) 7 On lobbying.ie
May–Aug 2019 Hanover Media Strategy Limited Finance Cost of Motor Insurance Policies in Ireland (Legislation) 13 On lobbying.ie
May–Aug 2019 Hanover Media Strategy Limited Health Creation of national policy with regard to Orphan Medicinal Products (Legislation) 4 On lobbying.ie
May–Aug 2019 Hanover Media Strategy Limited Housing Share experience of co-living and demonstrate The Collective's vision for successful co-living Dublin (Public policy or programme) 5 On lobbying.ie
May–Aug 2019 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines & engage government on healthcare innovation (Matters involving public funds) 15 On lobbying.ie
Jan–Apr 2019 Hanover Media Strategy Limited Health Creation of national policy with regard to Orphan Medicinal Products (Legislation) 5 On lobbying.ie
Jan–Apr 2019 Hanover Media Strategy Limited Finance Cost of Motor Insurance Policies in Ireland (Legislation) 27 On lobbying.ie
Jan–Apr 2019 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines (Matters involving public funds) 10 On lobbying.ie
Sep–Dec 2018 Hanover Media Strategy Limited Finance Finance Bill 2018 (Legislation) 13 On lobbying.ie
Sep–Dec 2018 Hanover Media Strategy Limited Finance Cost of Motor Insurance Policies in Ireland (Legislation) 21 On lobbying.ie
Sep–Dec 2018 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 10 On lobbying.ie
May–Aug 2018 Hanover Media Strategy Limited Heritage Amendment of secondary legislation governing the management of fauna trade permits under the Wildlife (Import and Export of Fauna and Flora) (Amendment) Regulations 2011 and the Convention on International Trade in… (Legislation) 6 On lobbying.ie
May–Aug 2018 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 13 On lobbying.ie
Jan–Apr 2018 Hanover Media Strategy Limited Health Reimbursement of Vimizim for Morquio A Syndrome (Matters involving public funds) 12 On lobbying.ie
Jan–Apr 2018 Hanover Media Strategy Limited Finance Consumer Protection for SMEs (Legislation) 7 On lobbying.ie
Jan–Apr 2018 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 12 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Reimbursement of Vimizim for Morquio A Syndome (Matters involving public funds) 16 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Telehealth policy in Ireland (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Funding of Mental Health Organisations (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Public policy or programme) 16 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 8 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Health Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Matters involving public funds) 18 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Health Reimbursement of Vimizim for Morquio A Syndome (Matters involving public funds) 8 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Health Rare Disease Medicines (Public policy or programme) 11 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Health Naltrexone for Opiate Addiction (Matters involving public funds) 4 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Health Telehealth policy in Ireland (Public policy or programme) 9 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Economic Development and Industry Engagement in relation to Companies Act 2014 on behalf of Coalition for Irish International Companies (Legislation) 8 On lobbying.ie
Jan–Apr 2017 Hanover Media Strategy Limited Health Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Matters involving public funds) 19 On lobbying.ie
Jan–Apr 2017 Hanover Media Strategy Limited Economic Development and Industry Engagement in relation to Companies Act 2014 on behalf of Coalition for Irish International Companies (Legislation) 24 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 79 42.7%
Transport 53 28.6%
Economic Development and Industry 13 7.0%
Energy and Natural Resources 10 5.4%
Children and Youth Affairs 9 4.9%
Finance 9 4.9%
Sports and Recreation 5 2.7%
Communications 2 1.1%
Arts 1 0.5%
Environment 1 0.5%
Heritage 1 0.5%
Housing 1 0.5%
Taxation 1 0.5%